AIRLINK 74.00 Decreased By ▼ -0.25 (-0.34%)
BOP 5.14 Increased By ▲ 0.09 (1.78%)
CNERGY 4.55 Increased By ▲ 0.13 (2.94%)
DFML 37.15 Increased By ▲ 1.31 (3.66%)
DGKC 89.90 Increased By ▲ 1.90 (2.16%)
FCCL 22.40 Increased By ▲ 0.20 (0.9%)
FFBL 33.03 Increased By ▲ 0.31 (0.95%)
FFL 9.75 Decreased By ▼ -0.04 (-0.41%)
GGL 10.75 Decreased By ▼ -0.05 (-0.46%)
HBL 115.50 Decreased By ▼ -0.40 (-0.35%)
HUBC 137.10 Increased By ▲ 1.26 (0.93%)
HUMNL 9.95 Increased By ▲ 0.11 (1.12%)
KEL 4.60 Decreased By ▼ -0.01 (-0.22%)
KOSM 4.83 Increased By ▲ 0.17 (3.65%)
MLCF 39.75 Decreased By ▼ -0.13 (-0.33%)
OGDC 138.20 Increased By ▲ 0.30 (0.22%)
PAEL 27.00 Increased By ▲ 0.57 (2.16%)
PIAA 24.24 Decreased By ▼ -2.04 (-7.76%)
PIBTL 6.74 Decreased By ▼ -0.02 (-0.3%)
PPL 123.62 Increased By ▲ 0.72 (0.59%)
PRL 27.40 Increased By ▲ 0.71 (2.66%)
PTC 13.90 Decreased By ▼ -0.10 (-0.71%)
SEARL 61.75 Increased By ▲ 3.05 (5.2%)
SNGP 70.15 Decreased By ▼ -0.25 (-0.36%)
SSGC 10.52 Increased By ▲ 0.16 (1.54%)
TELE 8.57 Increased By ▲ 0.01 (0.12%)
TPLP 11.10 Decreased By ▼ -0.28 (-2.46%)
TRG 64.02 Decreased By ▼ -0.21 (-0.33%)
UNITY 26.76 Increased By ▲ 0.71 (2.73%)
WTL 1.38 No Change ▼ 0.00 (0%)
BR100 7,874 Increased By 36.2 (0.46%)
BR30 25,599 Increased By 139.8 (0.55%)
KSE100 75,342 Increased By 411.7 (0.55%)
KSE30 24,214 Increased By 68.6 (0.28%)

imageFRANKFURT: German kidney dialysis specialist Fresenius Medical Care (FMC) said investors may have to wait until 2016 for profit growth, as it cuts costs to counter pressure on reimbursement for dialysis treatments in the United States and amid a foray into new healthcare services.

FMC, which operates more than a third of the dialysis treatment centres in the United States, on Wednesday forecast net income to stagnate or grow by up to 5 percent in 2015 but to increase by 15-20 percent next year, based on current exchange rates prevailing at the beginning of 2015.

Analysts had on average hoped for net income growth of more than 12 percent this year and their expectations for an annual dividend of about 0.90 euros were also far ahead of FMC's proposed payout of 0.78 euros per share.

DZ Bank analyst Sven Kuerten described the outlook as rather disappointing; adding the forecast growth acceleration in 2016 "closes the gap to the estimates somewhat".

US state-run insurer Medicare changed the way it pays for medical services, giving clinic operators a financial incentive to reduce costs and use fewer drugs. Medicare no longer pays for individual services and drugs but instead makes lump-sum reimbursements per dialysis session.

In addition to cutting costs, FMC has embarked on buying a range of healthcare services companies in the so-called care coordination segment, seeking to offer a bundle of treatments for chronic kidney and cardiovascular disease to Medicare and private-sector insurers.

"The outlook reflects further operating cost investments within the Care Coordination segment for future growth," the company said.

Fourth-quarter net income of $335 million, down 4 percent, was broadly in line with analyst expectations.

German healthcare group Fresenius SE, which controls FMC, said separately it expected its adjusted net income to rise between 9 and 12 percent at constant currencies this year, helped by additional earnings from the purchase of new hospitals and demand for healthcare services.

Copyright Reuters, 2015

Comments

Comments are closed.